Barclays’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.79M | Sell |
|
|||||
|
2025
Q2 | $4.6M | Buy |
|
|||||
|
2025
Q1 | $3.56M | Sell |
|
|||||
|
2024
Q4 | $14.7M | Sell |
|
|||||
|
2024
Q3 | $18.3M | Sell |
|
|||||
|
2024
Q2 | $20.4M | Buy |
|
|||||
|
2024
Q1 | $15.2M | Buy |
|
|||||
|
2023
Q4 | $7.58M | Buy |
|
|||||
|
2023
Q3 | $5.54M | Buy |
|
|||||
|
2023
Q2 | $7.09M | Sell |
|
|||||
|
2023
Q1 | $8.89M | Sell |
|
|||||
|
2022
Q4 | $14.3M | Sell |
|
|||||
|
2022
Q3 | $20.4M | Sell |
|
|||||
|
2022
Q2 | $30.1M | Sell |
|
|||||
|
2022
Q1 | $66.9M | Sell |
|
|||||
|
2021
Q4 | $104M | Buy |
|
|||||
|
2021
Q3 | $133M | Buy |
|
|||||
|
2021
Q2 | $146M | Buy |
|
|||||
|
2021
Q1 | $97.2M | Buy |
|
|||||
|
2020
Q4 | $47.8M | Buy |
|
|||||
|
2020
Q3 | $28.4M | Buy |
|
|||||
|
2020
Q2 | $23.9M | Sell |
|
|||||
|
2020
Q1 | $25M | Buy |
|
|||||
|
2019
Q4 | $8.41M | Buy |
|
|||||
|
2019
Q3 | $4.61M | Buy |
|
|||||
|
2019
Q2 | $3.9M | Buy |
|
|||||
|
2019
Q1 | $1.77M | Buy |
|
|||||
|
2018
Q4 | $1.21M | Sell |
|
|||||
|
2018
Q3 | $3.76M | Buy |
|
|||||
|
2018
Q2 | $561K | Sell |
|
|||||
|
2018
Q1 | $705K | Sell |
|
|||||
|
2017
Q4 | $7.54M | Buy |
|
|||||
|
2017
Q3 | $332K | Buy |
|
|||||
|
2017
Q2 | $319K | Sell |
|
|||||
|
2017
Q1 | $447K | Sell |
|
|||||
|
2016
Q4 | $407K | Buy |
|
|||||
|
2016
Q3 | $253K | Buy |
|
|||||
|
2016
Q2 | $179K | Hold |
|
|||||
|
2016
Q1 | $100K | Sell |
|
|||||
|
2015
Q4 | $202K | Buy |
|
|||||
|
2015
Q3 | $148K | Buy |
|